Abstract | BACKGROUND: The morbidity and mortality rate of liver cancer continues to rise in China and advanced cases respond poorly to chemotherapy. Ribosomal protein L24 has been reported to be a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cell growth of cancer. MATERIALS AND METHODS: Total RNA of cultured amycin-resistant and susceptible HepG2 cells was isolated, and real time quantitative RT-PCR were used to indicate differences between amycin-resistant and susceptible strains of HepG2 cells. Viability assays were used to determine amycin resistance in RPL24 transfected and control vector and null- transfected HepG2 cell lines. RESULTS: The ribosomal protein L24 transcription level was 7.7 times higher in the drug-resistant HepG2 cells as compared to susceptible cells on quantitative RT-PCR analysis. This was associated with enhanced drug resistance as determined by methyl tritiated thymidine (3H-TdR) incorporation. CONCLUSIONS:
|
Authors | Yong-Li Guo, Qing-Sheng Kong, Hong-Sheng Liu, Wen-Bin Tan |
Journal | Asian Pacific journal of cancer prevention : APJCP
(Asian Pac J Cancer Prev)
Vol. 15
Issue 22
Pg. 9853-7
( 2014)
ISSN: 2476-762X [Electronic] Thailand |
PMID | 25520117
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Guanidines
- RNA, Messenger
- Ribosomal Proteins
- ribosomal protein L24
- amycin A
|
Topics |
- Apoptosis
(drug effects)
- Carcinoma, Hepatocellular
(drug therapy, genetics, pathology)
- Cell Proliferation
(drug effects)
- Drug Resistance, Neoplasm
(genetics)
- Guanidines
(pharmacology)
- Hep G2 Cells
- Humans
- Liver Neoplasms
(drug therapy, genetics, pathology)
- RNA, Messenger
(genetics)
- Real-Time Polymerase Chain Reaction
- Reverse Transcriptase Polymerase Chain Reaction
- Ribosomal Proteins
(genetics, metabolism)
|